COMMUNIQUÉS West-GlobeNewswire

Cytokinetics to Announce Third Quarter Results on November 4, 2026
21/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 4, 2026 at 4:00 PM Eastern Time. [...]
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
21/10/2026
WESTLAKE VILLAGE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
BioCryst to Report Third Quarter 2026 Financial Results on November 4
21/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial results on Wednesday, November [...]
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
21/10/2026
SAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced that the U.S. Food [...]
Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026
21/10/2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a global, commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for [...]
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
21/10/2026
REDWOOD CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the [...]
SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
21/10/2026
JERSEY CITY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX) (“SCYNEXIS” or the “Company”), a clinical-stage biotechnology company dedicated to advancing innovative solutions for severe rare [...]
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
21/10/2026
SAN JOSE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
21/10/2026
FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after [...]
Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
21/10/2026
MENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
EmblemHealth Celebrates New York’s Labor Leaders at 14th Annual Heroes of Labor Awards
21/10/2026
Annual celebration recognized advocates for worker’s rights, safety, and well-being across New York City Left to right: Christine O’Connor, AVP, NYC Strategic Relationships, EmblemHealth, Karen Ignagni, Chief Executive [...]
Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
21/10/2026
Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major depressive disorder (“MDD”) on track for Q4 2026 1,2 HLP004 Program progressing with Phase 2 [...]
Kane Engages Independent Trading Group as Market Maker
21/10/2026
Agreement intended to support an orderly market and improve liquidity in Kane Biotech’s common shares WINNIPEG, Manitoba, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
21/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 21. Oct 2026 / 18:00 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
21/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 21. Oct 2026 / 18:01 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
21/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 21. Oct 2026 / 18:03 CET/CEST, transmitted by [...]
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
21/10/2026
Leo International Precision Health AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution 21. Oct 2026 / 18:05 CET/CEST, transmitted by [...]
Rendever Introduces Nova, an AI Life Enrichment Assistant, to CommunityOS
21/10/2026
New assistant gives resident engagement teams an intelligence layer designed to connect programming to resident outcomes BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Rendever , the leading provider of evidence-based social [...]
Major shareholder announcement - BlackRock, Inc.
21/10/2026
ANNOUNCEMENT NO. 322 21 October 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 15 October 2026, BlackRock, Inc. reduced [...]

Pages